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Abstract
Background Necrotising fasciitis (NF) is a rapidly progressive, destructive soft tissue infection with high mortality.
The primary aim of this study was to evaluate the incidence and mortality of NF amongst patients admitted to English
National Health Service (NHS) hospitals. The secondary aims included the identification of risk factors for mortality
and causative pathogens.
Methods The Hospital Episodes Statistics database identified patients with NF admitted to English NHS Trusts from
1/1/2002 to 31/12/2017. Information on patient demographics, co-morbid conditions, microbiology specimens,
surgical intervention and in-hospital mortality was collected. Uni- and multivariable analyses were performed to
investigate factors related to in-hospital mortality.
Results A total of 11,042 patients were diagnosed with NF. Age-standardised incidence rose from 9 per million in
2002 to 21 per million in 2017 (annual percentage change = 6.9%). Incidence increased with age and was higher in
men. Age-standardised mortality rate remained at 16% over the study period, while in-hospital mortality declined. On
multivariable analysis, the following factors were associated with increased risk of in-hospital mortality: emergency
admission, female sex, history of congestive heart failure, peripheral vascular disease, chronic kidney disease and
cancer. Admission year and diabetes, which was significantly prevalent at 27%, were not associated with increased
risk of mortality. Gram-positive pathogens, particularly Staphylococci, decreased over the study period with a
corresponding increase in Gram-negative pathogens, predominantly E. coli.
Conclusion The incidence of NF increased markedly from 2002 to 2017 although in-hospital mortality did not
change. There was a gradual shift in the causative organisms from Gram-positive to Gram-negative.
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Introduction
Necrotising fasciitis (NF) is a rapidly progressing soft tis-
sue infection that frequently results in permanent disability
and death despite parenteral antibiotic therapy and
aggressive surgical management [1–4]. NF usually starts as
a local infection from an abrasion, scratch or bite [5, 6].
The patient may present with cellulitis, which rapidly
progresses with pain disproportionate to the area of infec-
tion [7]. The infection spreads to the fascial layer and then
laterally along this plane with superficial tissue necrosis.
Diabetes, renal disease and increasing age have been
associated with poor outcomes [8, 9].
Necrotising fasciitis may be caused by a variety of
aerobic and facultative anaerobic bacterial species, but is
frequently polymicrobial. As many as 4 or 5 species may
be cultured and the contribution of each to the pathogenesis
of the disease is often not clear [1, 10]. Infections have
been divided into three categories determined by the iso-
lated species into polymicrobial, Group A streptococcal
(80–90%) and Gram-negative rods infections [8, 11–13].
The incidence of NF has been described in the USA,
with 4.8 deaths per 1,000,000 person years without a
change in incidence between 2002 and 2013 [8]. In this
study, by Arif and colleagues of 9871 cases of NF, strep-
tococcal species were identified in 48% (260/546) deaths
with a microbiological diagnosis, staphylococcal species in
22% (119/546) and Gram-negative species in 21% (114/
546). In this study, diabetes, renal disease and obesity were
associated with mortality. An increase in incidence has
been reported in New Zealand from 0.18 per 100,000
person-years in 1990 to 1.69 in 2006 and mortality from 0
to 0.3 per 100,000 person-years. In this latter study, disease
risk was the highest in the elderly, males, and Pacific and
Maori populations; however, microbiology was not repor-
ted [14]. There are no studies describing the incidence in
England, where the estimated incidence and microbiology
are unknown [1, 14–18].
The primary aim of this study was to determine the
incidence and associated mortality of NF in England. The
secondary aims were to investigate risk factors for mor-
tality and causative pathogens in patients admitted with a
diagnosis of NF in English NHS Hospitals over the study
period.
Methods
The Clinical Audit Committee of the University Hospitals
Birmingham NHS Foundation Trust approved the study.
Patients were identified from the Hospital Episode Statis-
tics (HES) database, with those admitted to an English
NHS Hospital, who were discharged between 1 January
2002 and 31 December 2017. Patients with a diagnosis of
NF were identified using the tenth revision of the Inter-
national Classification of Disease (ICD-10) code M72.5
assigned to the diagnostic fields of the first episode of each
admission and M72.6 when introduced in 2008 [19].
Transfers between hospitals (434 patients) and readmis-
sions with the same diagnosis were excluded. Pre-specified
patient level data items for collection were identified and
extracted from HES to include the date of admission and
discharge, the hospital attended, demographic characteris-
tics (age, gender, ethnicity, socio-economic status by
postcode), diagnostic (co-morbid conditions) and proce-
dural (surgical debridement, fasciotomy, skin grafting)
codes, microbiological samples taken (using ICD-10
codes) and in-hospital mortality. Search terms and syn-
onyms for procedural interventions were selected from the
Office of Population, Censuses and Surveys Classification
of Surgical Operations and Procedures, 4th revision
(OPCS-4) [20] (listed in Appendix A). The subgroup of
patients admitted as an emergency who underwent surgery
for NF were analysed.
Statistical methods
Age-standardised incidence rates were calculated using the
European Standard Population 2013. Change over time was
monitored using annual population change statistics
obtained from ONS mid-year population estimates fol-
lowing the 2011 census. Data on diabetes mellitus (DM)
prevalence were obtained through the Quality and Out-
come Framework (QOF) [21]. Incidence rates of NF in the
population with DM were determined using HES and QOF
data. Social deprivation was classified by postal code
(English Indices of Deprivation, Ministry of Housing,
Communities and Local Government). In-hospital mortal-
ity was measured. Patients with missing gender and age
were removed from the data set. Unknown categories for
ethnicity and deprivation were included. Patients with
missing microbiological data were excluded in the analysis
of changes in the proportions of causative organisms.
Univariable analysis was performed to identify factors
influencing in-hospital mortality to include in a multivari-
able model. All analyses were conducted using Stata SE
v13 [22].
Internal validation
To confirm the accuracy of NF diagnoses, a random sample
of 12 hospitals was chosen from the 160 acute hospitals in
England to provide a representative sample of the complete
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cohort. Patients with a diagnosis of NF (M72.5 in ICD-10)
who underwent in-hospital surgical debridement were
randomly selected at each of the 12 hospitals over the
10-year study period using a computer-generated method
by a trained, blinded coder at each Trust’s coding depart-
ment. A blinded Consultant Microbiologist at each hospital
reviewed the microbiology and pathology records for tissue
samples taken at surgery for each patient to determine the
accuracy of the diagnosis. Pre-specified patient-level data
were collected using an anonymised questionnaire. A
diagnosis of NF was accepted as accurate in the presence of
a positive culture of one or more pathogens known to cause
NF from local tissue swabs and/or blood cultures, or his-
tological necrosis in debrided fascial and subcutaneous
local tissue at surgery or autopsy.
Results
Data accuracy and missing data
Initially, 14,659 admissions to hospital for NF were iden-
tified between 1 January 2002 and 31 December 2017,
using the ICD10 code M72.5 and M72.6. Missing patient
age or gender excluded 16 admissions. A further 285
admissions were excluded because they were not resident
in England, and thus follow-up data were not reliable.
There were 2067 patients who had multiple admissions, so
only the first was kept for analysis, excluding 3314
admissions, leaving 11,042 patients. Coding completion for
ethnicity improved over the study period from 72.6% in
2002 to 94% in 2017.
The validation study provided 275 randomly selected
patients with an ICD-10 diagnosis of NF, which repre-
sented 4% of the total cohort who underwent in-hospital
surgical debridement. In total, 212 patients had a record of
a wound swab or tissue sampling at surgery of which 179
(81%) had microbiological and/or pathological confirma-
tion of NF.
Patient characteristics
There were 11,042 patients in the study with a median age
at diagnosis of 58 years (IQR 26). There were 5819
(52.7%) males, and the median male age was 57 (IQR 25)
compared with 59 for females (IQR 28) (Table 1). The
ethnic structure reflected that of the UK population
(Table 1) [23]. There were 3111 patients (28.2%) from the
most deprived socio-economic quintile, compared with
1610 (14.6%) from the least deprived (Table 1).
The most common co-morbidities were diabetes (2941;
26.6%), peripheral vascular disease (PVD) (1537; 13.9%)
and pulmonary disease (1514; 13.7%) (Table 1). The pelvic
region and thigh were the most common site for NF (3029;
27.4%) followed by the lower leg (1271; 11.5%) (Table 1).
Only 640 patients (5.8%) had been admitted with cellulitis
in the 30 days preceding their NF admission. In total, 1551
(14.0%) patients had been treated for cellulitis previously
in hospital.
Incidence and mortality of necrotising fasciitis
The age-standardised rate of admissions of NF doubled
from 2002 to 2017 (p\ 0.001, Fig. 1). This increase was
observed in both sexes and was higher for men at all ages
than women, with rate of admission increasing with age.
The rate of mortality of patients admitted with NF across
the study period was 16% and did not change statistically
(p = 0.237).
A multivariable analysis showed that in-hospital mor-
tality was higher for women (OR 1.28; 1.16–1.41,
p\ 0.0001) yet was not significantly higher at 1 year
(p = 0.573) compared to men. Patients from the most
deprived socio-economic quintile had the highest rate of
1-year mortality. Co-morbidities significantly increased in-
hospital mortality with the exception of diabetes, which did
not increase the in-hospital mortality (OR 1.01; 0.91–1.11,
p = 0.9042) (Table 2). Although most patients were
emergency admissions, there were 951 elective hospital
patients who later developed NF. Necrotising fasciitis of
the extremities (the feet or hands) were associated with
increased survival by one year (Table 3).
Emergency admissions requiring surgery
Of the subgroup of emergency admissions receiving sur-
gery, there were 6764 patients in total with a median age of
57 (IQR 44–68 years). There were 3723 men (55.0%), and
the median male age was 56 (IQR 44–68) compared to
57 years for women (IQR 44–69). The ethnic structure was
similar to the UK population with similar numbers of co-
morbidities (Table 1).
Surgical intervention became more common over the
study period with 190 patients receiving an intervention
(debridement, amputation or grafting) in 2002 compared to
602 in 2017. However, the timing of surgical intervention
from admission remained constant across the study period
with the median time from admission to surgery being
1 day: debridement 1 day; to amputation 1 day and skin
grafting 12 days (IQR 5–22).
Patients who underwent surgery on the same day as
admission were more likely to die during their admission
than those operated on later (23.1% vs. 20.2%, p = 0.006)
after accounting for all other factors (co-morbidities, age,
socio-economic deprivation, etc.). This remained true for
deaths at 30 and 90 days.
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Incidence and mortality for surgical patients
Age-standardised incidence for NF patients requiring sur-
gery increased from 4 to 20 per million across the study
period (Fig. 2). However, the mortality rate of NF
remained constant across the study period (p = 0.19). Age-
specific rate of admission to hospital with NF was higher
for men than women at all ages.
Table 1 Patient demographics
Patients (%)
Gender Male 5819 (52.7)
Female 5223 (47.3)
Age group Under 10 195 (1.8)
10–19 152 (1.4)
20–29 532 (4.8)
30–39 1170 (10.6)
40–49 1773 (16.1)
50–59 2070 (18.7)
60–69 2223 (20.1)
70–79 1743 (15.8)
80 ? 1184 (10.7)
Ethnicity White 9771 (88.5)
Asian 368 (3.3)
Black 279 (2.5)
Chinese, Other 186 (1.7)
Unknown 438 (4.0)
Deprivation quintile 1—Most deprived 3111 (28.2)
2 2413 (21.9)
3 1971 (17.9)
4 1832 (16.6)
5—Least deprived 1610 (14.6)
Unknown 105 (1.0)
Diabetes 2941 (26.6)
Peripheral vascular disease 1537 (13.9)
Pulmonary disease 1514 (13.7)
Co-morbidities Chronic kidney disease 1134 (10.3)
Congestive heart failure 809 (7.3)
Cancer 1134 (10.3)
Cellulitis with previous 30 days 640 (5.8)
Location Ankle and foot 533 (4.8)
Arm—Unspecified 59 (0.5)
Forearm 279 (2.5)
Hand 218 (2.0)
Leg 240 (2.2)
Lower leg 1271 (11.5)
Multiple sites 868 (7.9)
Other—including trunk, head etc.a 2855 (25.9)
Pelvic region and thigh 3029 (27.4)
Shoulder region 120 (1.1)
Upper arm 178 (1.6)
Unspecified 1392 (12.6)
aIt is not possible to break down this division further
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Diabetes
GP population data on diabetes were available from 2007
to 2017. During this time, the GP diabetic population rose
from 3.7 to 6.7%. However, the admissions of NF with
diabetes rose from 25.4% in 2007 to 34.5% in 2017.
Microbiological characteristics
An identified pathogen was recorded in 4446 (40.3%)
patients. Of surgical patients, 3306 patients (48.9)% had an
identified pathogen compared to 1140 (26.6%) patients
treated non-surgically. Gram-positive species represented
63.71% of all isolated pathogens (range per year from 55.9
to 75.7%) (Fig. 3). There was a reduction in the overall
proportion of Gram-positive species isolated over time
from 74.1% of all isolated pathogens in 2002 to 65.3% in
2017. This was largely due to a decrease in isolation of
staphylococci, where from intra-operative samples num-
bers fell 44.3% of all recorded pathogens in 2002 to 21.1%
in 2017 (Fig. 3). An increase in the overall proportion of
Gram-negative species isolated from intra-operative sam-
ples rose from 22.7% of all recorded pathogens in 2002 to
32.9% in 2017 due mainly to an increase in E. coli and
Klebsiella pneumoniae species (Fig. 3). Isolation of
anaerobes was low throughout the study period at 0.95%
(range 0.3–1.7%) of all isolated species. No geographical
hot spots of specific pathogens were identified.
Patients with Gram-negative species isolated had a
mortality rate of 22.7% within hospital, compared to
patients with Gram-positive species (p = 0.016). Patients
with Gram-negative bacteriology also had higher mortality
at 30 and 90 days and at 1 year than patients with Gram-
positive species. In-hospital mortality was 22.7% (487) for
patients with Gram-positive species, compared with 19.8%
(444) for Gram-negative (p = 0.016). The 30-day mortality
for Gram-positive species was 34.6% (741), but Gram-
negative was 26.9% (604) (p\ 0.0001). However, the
90-day mortality rose to 41.5% (890) for Gram-positive
compared to 33.3% (749) for Gram-negative and by one
year, the Gram-positive mortality rate was 44.0% (943),
but Gram-negative was 36.3% (816) (p\ 0.0001).
Discussion
This study has demonstrated a marked increase in the
incidence of NF admissions in England over a 16-year
period from 2002 to 2017 (Fig. 1). The dates for the study
period were chosen to evaluate 16 years of data and to
encompass the census of 2011. In line with these findings,
increased incidence of NF has been seen in other countries
including New Zealand and USA [14]. The relationship to
predisposing factors including DM, PVD, CKD, socio-
economic status, sex and age is consistent with previous
studies [2, 24].
Patients with diabetes (DM) are four times over-repre-
sented in the cohort, importantly; however, their mortality
was no greater than the rest of the population with NF.
Patients with DM increased by 62.3% over the study period
in line with increasing prevalence of DM worldwide, with
the UK population of patients with diabetes increased by
72.9% across the study period [25]. The observed increased
incidence of NF cannot therefore be explained by increased
prevalence of DM. The proportion of chronic diseases
predisposing to NF has been compared to that in the UK
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Fig. 1 Age standardised rate of
admissions to hospital for
patients with necrotising
fasciitis and of mortality. The
rate of admissions rose from 9
per million population in 2002
to 16 per million in 2017. The
rate of admissions resulting in
death remained constant across
the study period
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population using the QOF in General Practice which has
been previously validated but may underestimate the pop-
ulation [26–29].
An increase in the age-standardised death rate from NF
was seen in line with the observed increased incidence
(Fig. 1). Mortality remained constant across the study
period. However, the age-standardised mortality rate
reduced by 60% for patients admitted to hospital. An
increased risk of in-hospital mortality was seen with
emergency admission and in the presence of congestive
heart failure, PVD and CKD. Although there has been a
rise in the number of surgical interventions for patients
admitted as an emergency, the time from admission to
theatre remained unchanged over the study period. The rise
in the number of patients undergoing operative intervention
over the study period is likely due to increased awareness
of NF and recognition of the value of early surgical
debridement.
Of the cohort, 11,042 had ‘NF’ documented within
patient medical records with 6764 undergoing surgery.
Patients who underwent surgery on the day of admission
had a higher 30- and 90-day mortality than those who
underwent surgery after 24 h. This cohort likely represents
more unwell patients with a poorer prognosis requiring
immediate life-saving intervention. The reasons for man-
agement of patients without surgical intervention were not
possible to elucidate in this study. It may be that these
patients were unfit or died before surgery. Alternatively,
they have had a severe soft tissue infection and been
incorrectly coded as NF. The validation study of the sur-
gical cohort in 12 centres confirmed over 80% of cases was
correctly coded, suggesting that patients undergoing sur-
gery did have a true diagnosis of NF.
Importantly, a change in isolated pathogenic species
over the 10-year period was observed. Although the
majority of isolates were staphylococci and streptococci
species as in other studies, a falling number of isolated
Staphylococcus aureus strains and an increase in Gram-
negative species, predominantly E. coli and Klebsiella
pneumonia, in the absence of a change in anaerobic species
have been demonstrated. These data may reflect the
effectiveness of anti-MRSA interventions across UK hos-
pitals, which coincides with the study period [30, 31].
However, this pattern was also seen in patients presenting
as an emergency from the community. Polymicrobial NF is
the predominant form, and as many as 4 or 5 species may
be cultured from cases of NF. The contribution of each
isolated organism to the pathogenesis of the disease is often
not clear [1, 3, 10]. Although infection is frequently
polymicrobial, an increase in monomicrobial NF has also
been described in other sites [1, 3, 10]. From HES data, it
was not possible to identify a relative change in the
Fig. 2 Age standardised rate of admissions and of mortality for emergency admissions of patients with necrotising fasciitis requiring surgery.
For those patients with necrotising fasciitis receiving surgery, the rate of admission rose from 4 per million population in 2002 to 12
per million population in 2017. However the standardised rate of admissions that resulted in death fell during the study period
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incidence of monomicrobial and polymicrobial NF over
time, which may have influenced the relative proportions of
species isolated and underestimate responsible organisms.
We are only able to comment about the total numbers of
pathogens isolated from the cases of NF. The UK Stan-
dards for Microbiology Investigations guidelines for pro-
cessing of samples recommend incubation of samples for
investigation of skin, superficial and non-surgical wound
swabs in blood agar [32]. Wound swabs from chronic
ulcers, traumatic wounds and samples from abscesses and
deep-seated wound infections should be cultured in Neo-
mycin fastidious anaerobe agar with metronidazole 5 lg
disc [33]. We cannot comment on the culture media and
conditions used during sample processing over the study
period as these were completed by microbiology labora-
tories across all study sites. Although isolation of anaer-
obes was low throughout the study period, this may reflect
variation in culture techniques between centres. The find-
ings therefore may underestimate anaerobic species.
The increase in Gram-negative infections pathogens
isolated from NF cases has also been recently been
reported elsewhere [34–36]. Interestingly, Lee et al.
observed more frequent septic shock and higher risk of
mortality in patients with Gram-negative monomicrobial
NF [37]. It is important to note that the findings from that
study were seen in one hospital over a 9-year period with a
high incidence of isolated Gram-negative bacilli, predom-
inantly Vibrio species, in 76.1% of patients. This represents
an unusual aetiology in the UK and is likely associated
with the different geographical location of the Lee study.
The impact of alterations in isolated pathogenic species and
the effect of polymicrobial compared to monomicrobial
infections on outcome have not been formally evaluated. A
change in the balance of pathogens causing NF may have
implications for empirical antimicrobial therapy with
Gram-negative species presenting the greatest current
AMR challenge in hospital medicine.
There are several limitations of this observational
approach. The observed increased incidence may be due to
greater recognition of NF with improved levels of diag-
noses and coding. Whilst the proportion of patients cor-
rectly coded in HES cannot be determined, previous
publications support the use of routinely collected HES
data for research with improving accuracy rates [14, 38].
Further, we validated our findings by auditing a random
sample of 12 hospitals, which confirmed the accuracy of
81% of NF diagnoses for patients receiving surgery. To
improve data accuracy and completeness, patients with
missing data including gender and age and patients with
missing microbiological data were excluded in the analysis
of changes in the proportions of causative organisms.
Data on obesity and smoking were not collected, as these
were not routinely collected data items inHES over the study
period. In the UK, seven of ten British people will be over-
weight or obese by 2020 with 40% being obese by 2030
[39, 40]. As there is a clear association between rising levels
of obesity and increasing prevalence of DM, obesity may be
a contributing factor to the observed increased incidence of
NF, but this could not be determined by this study.
It is clear that a number of aspects of patient care cannot
be disclosed by the existing data sources including time of
onset and duration of symptoms, severity and prognosis at
presentation and diagnosis, management in the community,
death in patients who never had surgery due to co-morbid
Fig. 3 Change in pathogens
from patients receiving surgery
over time. Although the
proportion of Gram-positive
organisms overall fell during the
study period, streptococci specii
remained high whilst
staphylococci specii dropped.
Gram-negative isolated specii
became more common, in
particular E. coli
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disease or NF-related multi-organ failure, reasons for non-
surgical management or choice of antimicrobials, their
timing and frequency of administration. These factors
impact on outcome, and changes in practice over time
including earlier diagnosis, earlier admission to hospital for
intervention and advances in intensive care management
may explain the observed reduced in-hospital mortality.
Conclusion
Our results show an increasing incidence of NF in England
which is a cause for concern, but a reduction in in-hospital
mortality. The time to surgical intervention did not change
over the study period. These data support the establishment
of a national database to allow an ongoing audit of the
observed increased incidence and changes in pathogenic
species, which would inform future treatment strategies
and improved patient outcome.
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Appendix A: Surgical codes from OPCS-4
Amputation X07 Amputation of arm
X08 Amputation of hand
X09 Amputation of leg
X10 Amputation of foot
X11 Amputation of toe
N261 Total amputation of penis
N262 Partial amputation of penis
Debridement S541 Debridement of burnt skin of head or neck
S551 Debridement of burnt skin NEC
S561 Debridement of skin of head or neck
S571 Debridement of skin NEC
S573 Toilet of skin NEC
S581 Larvae debridement therapy of skin of head or
neck
S582 Larvae debridement therapy of skin NEC
T774 Debridement of muscle NEC
T963 Debridement of soft tissue NEC
Y055 Debridement of organ NOC
Graft S35 Split autograft of skin
S36 Other autograft of skin
S37 Other graft of skin
S38 Graft of mucosa
S39 Graft of other tissue to skin
Dressing S544 Dressing of burnt skin of head or neck NEC
S545 Attention to dressing of burnt skin of head or
neck
S547 Dressing of burnt skin of head or neck using
vacuum-assisted closure device
S554 Dressing of burnt skin NEC
S555 Attention to dressing of burnt skin NEC
S557 Dressing of burnt skin using vacuum-assisted
closure device NEC
S564 Dressing of skin of head or neck NEC
S565 Attention to dressing of skin of head or neck
NEC
S567 Dressing of skin of head or neck using
vacuum-assisted closure device
S574 Dressing of skin NEC
S575 Attention to dressing of skin NEC
S577 Dressing of skin using vacuum-assisted
closure device
Drainage H58 Drainage through perineal region
P14 Incision of introitus of vagina
T34 Open drainage of peritoneum
N244 Incision of male periurethral tissue
P131 Drainage of female perineum
X125 Drainage of amputation stump
N323 Incision of penis (NEC)
N322 Drainage of penis
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Appendix continued
S471 Drainage of lesion of skin of head or neck
S472 Drainage of lesion of skin NEC
S473 Incision of lesion of skin of head or neck
S474 Incision of lesion of skin NEC
S475 Incision of skin of head or neck
S476 Incision of skin NEC
Fasciotomy T55 Release of fascia
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